Answers are grounded in this paper and cite their sources.
Research reveals comparable performance of biomarkers in detecting subclinical atherosclerosis in elderly with type 2 diabetes, suggesting clinical applications.
In older adults with type 2 diabetes, 1,5-AG demonstrated a performance comparable to CGM for detecting abnormal CIMT, supporting its potential as a clinical biomarker for identifying subclinical atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Su et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: